Author Archives for Adeline Chauvigné

Valneva to Present on Lyme and Zika at the 18th World Vaccine Congress in Washington, D.C.

Presentations to feature progress on Lyme and Zika vaccine candidates Valneva SE (“Valneva” or “the Company”), a fully integrated, commercial... View Article

Rédigé par Adeline Chauvigné, le 2018-03-29

Valneva to Present on Lyme and Zika at the 18th World Vaccine Congress in Washington, D.C.

Presentations to feature progress on Lyme and Zika vaccine candidates Valneva SE (“Valneva” or “the Company”), a fully integrated, commercial... View Article

Valneva and its Single-Shot Vaccine Candidate against Chikungunya

Valneva Initiates Phase I Clinical Study to Evaluate Its Single-Shot Vaccine Candidate against Chikungunya Valneva SE, a fully integrated commercial... View Article

Rédigé par Adeline Chauvigné, le 2018-03-23

Valneva and its Single-Shot Vaccine Candidate against Chikungunya

Valneva Initiates Phase I Clinical Study to Evaluate Its Single-Shot Vaccine Candidate against Chikungunya Valneva SE, a fully integrated commercial... View Article

VitamFero announces that Clean Cells has created a cell bank for its Toxo KO vaccine strain

Following its recent industrial partnership signed with a world leader for animal health to develop its bovine neosporosis vaccine candidate,... View Article

Rédigé par Adeline Chauvigné, le 2018-03-29

VitamFero announces that Clean Cells has created a cell bank for its Toxo KO vaccine strain

Following its recent industrial partnership signed with a world leader for animal health to develop its bovine neosporosis vaccine candidate,... View Article

BIOREGATE FORUM: 2ND EDITION

SAVE THE DATE: BIOREGATE FORUM 2018  Bioregate forum 2018, an international congress dedicated to regenerative medicine, will be held from 12... View Article

Rédigé par Adeline Chauvigné, le 2018-02-28

BIOREGATE FORUM: 2ND EDITION

SAVE THE DATE: BIOREGATE FORUM 2018  Bioregate forum 2018, an international congress dedicated to regenerative medicine, will be held from 12... View Article

IHU CESTI: capitalising on research

Capitalising on research results is a vital step in the innovative strategy of IHU CESTI CESTI focuses on immune responses occurring... View Article

Rédigé par Adeline Chauvigné, le 2018-02-22

IHU CESTI: capitalising on research

Capitalising on research results is a vital step in the innovative strategy of IHU CESTI CESTI focuses on immune responses occurring... View Article

Medical Device Meetings

Together with its German partner, Bio Regio STERN, as part of the Boos4Health programme, Atlanpole biotherapies offers you a discount of €400... View Article

Rédigé par Adeline Chauvigné, le 2018-02-27

Medical Device Meetings

Together with its German partner, Bio Regio STERN, as part of the Boos4Health programme, Atlanpole biotherapies offers you a discount of €400... View Article

European Council Simulation: “Nantes becomes Brussels for a day”

60 STUDENTS FROM THE UNIVERSITY OF NANTES TO TAKE ON THE ROLES OF HEADS OF STATE AND GOVERNMENT CONCEPT Simulating... View Article

Rédigé par Adeline Chauvigné, le 2018-02-21

European Council Simulation: “Nantes becomes Brussels for a day”

60 STUDENTS FROM THE UNIVERSITY OF NANTES TO TAKE ON THE ROLES OF HEADS OF STATE AND GOVERNMENT CONCEPT Simulating... View Article

Brittany-based company Diafir joins the inter-regional cluster

Diafir, based in Rennes, has developed the SPIDTM platform for non-invasive diagnosis using infrared imaging. Using patented optics and proprietary algorithms, this platform allows... View Article

Cynbiose Respiratory joins the Atlanpole Biotherapies network

CYNBIOSE RESPIRATORY, A NEW PRECLINICAL SERVICES COMPANY SPECIALISING IN RESPIRATORY DISEASES AND AEROSOL THERAPY, IS NOW A MEMBER OF ATLANPOLE... View Article

Rédigé par Adeline Chauvigné, le 2018-02-21

Cynbiose Respiratory joins the Atlanpole Biotherapies network

CYNBIOSE RESPIRATORY, A NEW PRECLINICAL SERVICES COMPANY SPECIALISING IN RESPIRATORY DISEASES AND AEROSOL THERAPY, IS NOW A MEMBER OF ATLANPOLE... View Article

Big Pharmas meeting on bioproduction innovation in Nantes

Last week, in Nantes, the ACTIP (Animal Cell Technology Industrial Platform) organized a meeting for its members. Around  40 representatives... View Article

Rédigé par Adeline Chauvigné, le 2017-12-06

Big Pharmas meeting on bioproduction innovation in Nantes

Last week, in Nantes, the ACTIP (Animal Cell Technology Industrial Platform) organized a meeting for its members. Around  40 representatives... View Article